Press Releases

Hogan Lovells advises MorphoSys on global licensing and development of blood cancer drug tafasitamab

Led by its partners Jörg Schickert and Arne Thiermann, and in close collaboration with MorphoSys in-house deal counsel Virginie Galitschke, international law firm Hogan Lovells has...

Press Releases

Hogan Lovells advises Medicines Development for Global Health in the Sale of its Priority Review Voucher

New York, 14 May 2019 – A team from Hogan Lovells has advised Medicines Development for Global Health (MDGH) in the sale of its Priority Review Voucher (PRV).

Loading data